Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

In a groundbreaking Phase I/II trial conducted at Kyoto University Hospital, researchers have demonstrated the potential of iPS-cell-derived dopaminergic progenitors in treating Parkinson’s disease.

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with ...

Researchers have successfully developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that ...

The researchers believe that the stem-cell treatment indeed holds the key to stopping Parkinson's Disease in its tracks, a ...

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...